APOL1 channel blocker reduces proteinuria in FSGS

Kidney Int. 2023 Aug;104(2):228-230. doi: 10.1016/j.kint.2023.04.022. Epub 2023 May 22.
No abstract available

Keywords: chronic kidney disease; focal segmental glomerulosclerosis; nephrotic syndrome.

Publication types

  • Comment

MeSH terms

  • Apolipoprotein L1 / genetics
  • Glomerulosclerosis, Focal Segmental* / drug therapy
  • Humans
  • Kidney
  • Nephrotic Syndrome*
  • Proteinuria / drug therapy

Substances

  • Apolipoprotein L1
  • APOL1 protein, human